Skip to content

Nasdaq · CIK 0001464521

HTFL Heartflow, Inc.

Insider trading from SEC Form 4. Last filing 21 d ago. Close $49.74 on Oct 9, 2026, +143% from the 52-week low and -5% from the high.

Last 90 days

Net insider value
-$7.8M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
6
$7.8M by 3 insiders
Insiders on file
12
with a Form 4 at this company

Price and insider trades, last year

HTFLOct 9, 2026 · close 49.74

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Heartflow, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
25WeakCampbell Rogers
Chief Medical Officer
sell
$987k
19,682 shares
-20%-
47ModerateVikram Verghese
Chief Financial Officer
sell
$1.2M
24,345 shares
-14%-
47ModerateVikram Verghese
Chief Financial Officer
sell
$1.8M
34,975 shares
-16%-
50ModerateJohn C.M. Farquhar
Chief Executive Officer
sell
$1.8M
38,900 shares
-11%-
32WeakVikram Verghese
Chief Financial Officer
sell
$332k
6,640 shares
-3%-
40ModerateVikram Verghese
Chief Financial Officer
sell
$1.7M
33,416 shares
-13%-
42ModerateBain Capital Life Sciences Investors, LLC
owner
sell
$59M
2,000,000 shares
-19%+49% from low-23% from high
30WeakCampbell Rogers
Chief Medical Officer
sell
$1.7M
64,533 shares
-45%+26% from low-35% from high
33WeakJohn C.M. Farquhar
Chief Executive Officer
sell
$243k
9,725 shares
-2%+24% from low-36% from high
34WeakJohn C.M. Farquhar
Chief Executive Officer
sell
$291k
12,837 shares
-2%+9% from low-43% from high
33WeakJulie A Cullivan
director
sell
$228k
9,122 shares
-25%+20% from low-38% from high
30WeakCampbell Rogers
Chief Medical Officer
sell
$1.6M
65,153 shares
-46%0% from low-44% from high
40ModerateJohn C.M. Farquhar
Chief Executive Officer
sell
$620k
22,562 shares
-4%+7% from low-32% from high
57ModerateBain Capital Life Sciences Investors, LLC
owner
sell
$56M
2,000,000 shares
-16%+10% from low-29% from high
27WeakJulie A Cullivan
director
sell
$219k
8,000 shares
-18%+1% from low-35% from high
66NotableJeffrey C Lightcap
director
buy
$1.1M
40,000 shares
-+3% from low-34% from high

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 18, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+12,329$8.33$103k98,78821 d ago
Sep 18, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+850$2.22$1,88799,63821 d ago
Sep 18, 2026Campbell Rogers
Chief Medical Officer
SOpen-market sale
Common Stock10b5-1
-19,682$50.15$987k79,95621 d ago
Sep 18, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-12,329$0.00$031,45621 d ago
Sep 18, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-850$0.00$070,78321 d ago
Sep 17, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-7,579$50.11$380k171,94924 d ago
Sep 18, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-16,766$50.75$851k155,18324 d ago
Sep 11, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-29,714$50.06$1.5M184,78927 d ago
Sep 14, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-4,593$50.24$231k180,19627 d ago
Sep 15, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-668$50.01$33k179,52827 d ago
Sep 10, 2026John C.M. Farquhar
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-35,010$46.42$1.6M325,80428 d ago
Sep 11, 2026John C.M. Farquhar
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-3,890$50.00$195k321,91428 d ago
Sep 8, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-6,640$50.03$332k214,50332 d ago
Sep 2, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-5,876$50.60$297k248,68338 d ago
Sep 3, 2026Vikram Verghese
Chief Financial Officer
SOpen-market sale
Common Stock.10b5-1
-27,540$49.69$1.4M221,14338 d ago
Jun 16, 2026Timothy C Barabe
director
AGrant or award
Stock Optionderivative
+16,075$32.05$515k16,075Jun 18, 2026
Apr 28, 2026Bain Capital Life Sciences Investors, LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-254,110$30.51$7.8M10,194,048Apr 30, 2026
Apr 29, 2026Bain Capital Life Sciences Investors, LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-797,133$29.37$23M9,396,915Apr 30, 2026
Apr 30, 2026Bain Capital Life Sciences Investors, LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-892,533$29.18$26M8,504,382Apr 30, 2026
Apr 30, 2026Bain Capital Life Sciences Investors, LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-56,224$30.05$1.7M8,448,158Apr 30, 2026
Mar 24, 2026Jeffrey C Lightcap
director
JOther
Common Stock
+206,261$0.00$0246,261Mar 26, 2026
Mar 24, 2026HealthCor Partners Management LP
director
JOther
COMMON STOCKindirect: By HCPCIV I, LLC
-4,615,542--0Mar 26, 2026
Mar 19, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+19,402$2.22$43k95,436Mar 23, 2026
Mar 19, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+47,615$2.22$106k143,051Mar 23, 2026
Mar 19, 2026Campbell Rogers
Chief Medical Officer
SOpen-market sale
Common Stock10b5-1
-64,533$25.69$1.7M78,518Mar 23, 2026
Mar 19, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-19,402$0.00$0189,125Mar 23, 2026
Mar 19, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-47,615$0.00$0141,510Mar 23, 2026
Mar 18, 2026John C.M. Farquhar
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-9,725$25.00$243k571,725Mar 20, 2026
Mar 6, 2026John C.M. Farquhar
Chief Executive Officer
AGrant or award
Common Stock10b5-1
+2,631$16.15$42k594,287Mar 12, 2026
Mar 11, 2026Timothy C Barabe
director
MOption exercise
Common Stock
+8,667$2.22$19k179,521Mar 12, 2026
Mar 11, 2026Timothy C Barabe
director
MOption exercise
Stock Optionderivative
-8,667$0.00$015,412Mar 12, 2026
Mar 10, 2026John C.M. Farquhar
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-12,837$22.66$291k581,450Mar 12, 2026
Mar 5, 2026Julie A Cullivan
director
SOpen-market sale
Common Stock10b5-1
-9,122$25.00$228k27,291Mar 6, 2026
Feb 17, 2026Timothy C Barabe
director
MOption exercise
Common Stock
+2,497$8.33$21k170,854Feb 19, 2026
Feb 17, 2026Timothy C Barabe
director
MOption exercise
Stock Optionderivative
-2,497$0.00$00Feb 19, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+19,401$2.22$43k93,572Feb 17, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+39,709$8.33$331k133,281Feb 17, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Common Stock10b5-1
+7,906$2.22$18k141,187Feb 17, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
SOpen-market sale
Common Stock10b5-1
-65,153$24.49$1.6M76,034Feb 17, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-39,709$0.00$00Feb 17, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-19,401$0.00$0216,433Feb 17, 2026
Feb 12, 2026Campbell Rogers
Chief Medical Officer
MOption exercise
Stock Optionderivative10b5-1
-7,906$0.00$0208,527Feb 17, 2026
Feb 6, 2026Campbell Rogers
Chief Medical Officer
FTax withholding
Common Stock
-515$27.74$14k20,098Feb 10, 2026
Feb 6, 2026John C.M. Farquhar
Chief Executive Officer
FTax withholding
Common Stock10b5-1
-1,541$27.74$43k430,368Feb 10, 2026
Feb 6, 2026Vikram Verghese
Chief Financial Officer
FTax withholding
Common Stock.
-542$27.74$15k144,370Feb 10, 2026
Feb 6, 2026Marie L. Jones
Chief Accounting Officer, VP
FTax withholding
Common Stock.
-94$27.74$2,60810,021Feb 10, 2026
Feb 6, 2026John C.M. Farquhar
Chief Executive Officer
AGrant or award
Common Stock10b5-1
+183,850$0.00$0614,218Feb 10, 2026
Feb 6, 2026Vikram Verghese
Chief Financial Officer
AGrant or award
Common Stock.
+68,493$0.00$0212,863Feb 10, 2026
Feb 6, 2026Campbell Rogers
Chief Medical Officer
AGrant or award
Common Stock
+54,073$0.00$074,171Feb 10, 2026
Feb 6, 2026Marie L. Jones
Chief Accounting Officer, VP
AGrant or award
Common Stock.
+21,629$0.00$031,650Feb 10, 2026
Feb 10, 2026John C.M. Farquhar
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-22,562$27.46$620k591,656Feb 10, 2026
Feb 6, 2026Vikram Verghese
Chief Financial Officer
AGrant or award
Stock Optionderivative
+119,685$0.00$0119,685Feb 10, 2026
Feb 6, 2026Marie L. Jones
Chief Accounting Officer, VP
AGrant or award
Stock Optionderivative
+37,795$0.00$037,795Feb 10, 2026
Feb 6, 2026John C.M. Farquhar
Chief Executive Officer
AGrant or award
Stock Optionderivative10b5-1
+321,259$0.00$0321,259Feb 10, 2026
Feb 6, 2026Campbell Rogers
Chief Medical Officer
AGrant or award
Stock Optionderivative
+94,488$0.00$094,488Feb 10, 2026
Feb 5, 2026Julie A Cullivan
director
SOpen-market sale
Common Stock10b5-1
-8,000$27.32$219k36,413Feb 6, 2026
Feb 4, 2026Bain Capital Life Sciences Investors, LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-2,000,000$28.05$56M10,448,158Feb 6, 2026
Dec 16, 2025Jeffrey C Lightcap
director
POpen-market purchase
Common Stock
+40,000$26.34$1.1M40,000Dec 17, 2025
Nov 7, 2025John C.M. Farquhar
Chief Executive Officer
FTax withholding
Common Stock
-1,339$32.56$44k431,909Nov 12, 2025
Nov 7, 2025Marie L. Jones
Chief Accounting Officer, VP
FTax withholding
Common Stock.
-81$32.56$2,63710,115Nov 12, 2025
Nov 7, 2025Vikram Verghese
Chief Financial Officer
FTax withholding
Common Stock.
-471$32.56$15k144,912Nov 12, 2025
Nov 7, 2025Campbell Rogers
Chief Medical Officer
FTax withholding
Common Stock
-439$32.56$14k20,613Nov 12, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Common Stockindirect: By HealthCor Partners Fund, L.P.
+1,248,939--1,248,939Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Common Stockindirect: By HealthCor Partners Fund II, L.P.
+833,075--833,075Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Common Stockindirect: By HCPCIV 1, LLC
+4,615,542--4,615,542Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series C Preferredderivativeindirect: By HealthCor Partners Fund, L.P.
-1,248,939--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series C Preferred Stockderivativeindirect: By HealthCor Partners Fund II, L.P.
-624,471--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series D Preferredderivativeindirect: By HCPCIV 1, LLC
-1,630,231--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series D Preferredderivativeindirect: By HealthCor Partners Fund II, L.P.
-208,604--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series E Preferred Stockderivativeindirect: By HCPCIV 1, LLC
-1,099,378--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series F Preferred Stockderivativeindirect: By HCPCIV 1, LLC
-1,337,337--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Series F-1 Preferred Stockderivativeindirect: By HCPCIV 1, LLC
-452,528--0Aug 22, 2025
Aug 11, 2025HealthCor Partners Management LP
owner
CConversion
Convertible Promissory Notederivativeindirect: By HCPCIV 1, LLC
-96,068--0Aug 22, 2025
Aug 11, 2025Bain Capital Life Sciences Investors, LLC
owner
CConversion
Common Stockindirect: See footnotes
+12,014,234--12,014,234Aug 13, 2025
Aug 11, 2025Bain Capital Life Sciences Investors, LLC
owner
CConversion
Common Stockindirect: See footnotes
+433,924$15.20$6.6M12,448,158Aug 13, 2025
Aug 11, 2025Bain Capital Life Sciences Investors, LLC
owner
CConversion
Series F Preferred Stockderivativeindirect: See footnotes
-35,081,564$0.00$00Aug 13, 2025
Aug 11, 2025Bain Capital Life Sciences Investors, LLC
owner
CConversion
Subordinated Convertible Promissory Notederivativeindirect: See footnotes
-$0.00-0Aug 13, 2025
Aug 11, 2025Jeffrey C Lightcap
director
CConversion
Common Stockindirect: By HealthCor Partners Fund II, L.P.
+833,075--833,075Aug 11, 2025
Aug 7, 2025Marie L. Jones
Chief Accounting Officer, VP
AGrant or award
Common Stock
+3,618$0.00$03,618Aug 11, 2025
Aug 7, 2025Wayne Joseph Riley
director
AGrant or award
Stock Optionderivative
+23,710$0.00$023,710Aug 11, 2025
Aug 11, 2025William C Weldon
director
CConversion
Common Stock
+136,286--192,562Aug 11, 2025
Aug 11, 2025Casey M Tansey
director
CConversion
Common Stockindirect: By U.S. Venture Partners X, L.P.
+3,072,759--3,072,759Aug 11, 2025
Aug 7, 2025Vikram Verghese
Chief Financial Officer
AGrant or award
Common Stock
+21,052$0.00$0135,867Aug 11, 2025
Aug 7, 2025John C.M. Farquhar
Chief Executive Officer
AGrant or award
Common Stock
+59,868$0.00$0433,248Aug 11, 2025
Aug 7, 2025Campbell Rogers
Chief Medical Officer
AGrant or award
Common Stock
+21,052$0.00$021,052Aug 11, 2025
Aug 7, 2025Julie A Cullivan
director
AGrant or award
Stock Optionderivative
+23,710$0.00$023,710Aug 11, 2025
Aug 11, 2025Timothy C Barabe
director
CConversion
Common Stock
+131,578--168,357Aug 11, 2025
Aug 11, 2025Jeffrey C Lightcap
director
CConversion
Common Stockindirect: By HealthCor Partners Fund, L.P.
+1,248,939--1,248,939Aug 11, 2025
Aug 7, 2025Timothy C Barabe
director
AGrant or award
Stock Optionderivative
+23,710$0.00$023,710Aug 11, 2025
Aug 11, 2025Vikram Verghese
Chief Financial Officer
CConversion
Common Stock.
+9,516--145,383Aug 11, 2025
Aug 11, 2025Marie L. Jones
Chief Accounting Officer, VP
CConversion
Common Stock.
+6,578--10,196Aug 11, 2025
Aug 11, 2025Casey M Tansey
director
CConversion
Common Stockindirect: By USVP X Affiliates, L.P.
+98,303--98,303Aug 11, 2025
Aug 7, 2025William C Weldon
director
AGrant or award
Stock Optionderivative
+23,710$0.00$023,710Aug 11, 2025
Aug 7, 2025John C.M. Farquhar
Chief Executive Officer
AGrant or award
Stock Optionderivative
+314,603$0.00$0314,603Aug 11, 2025
Aug 11, 2025Timothy C Barabe
director
CConversion
Convertible Promissory Notederivative
-131,578$0.00$00Aug 11, 2025
Aug 11, 2025Jeffrey C Lightcap
director
CConversion
Common Stockindirect: By HCPCIV 1, LLC
+4,615,542--4,615,542Aug 11, 2025
Aug 11, 2025Casey M Tansey
director
CConversion
Common Stock
+16,447--16,447Aug 11, 2025
Mar 13, 2025Marie L. Jones
Chief Accounting Officer, VP
AGrant or award
Stock Optionderivative
+68,492$0.00$068,492Aug 11, 2025
Aug 7, 2025Vikram Verghese
Chief Financial Officer
AGrant or award
Stock Optionderivative
+110,629$0.00$0110,629Aug 11, 2025
Aug 11, 2025William C Weldon
director
CConversion
Series D Preferred Stockderivative
-83,442--0Aug 11, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

HTFL insider trading: Heartflow, Inc. | InsiderTell